Homoharringtonine suppresses gastric cancer progression by targeting PI3K/ AKT/FOXO pathway and impairing the GSH-GPX4 antioxidant axis.

Synribo (omacetaxine mepesuccinate) - Teva

http://www.ncbi.nlm.nih.gov/pubmed/42050199

Haonan Jin; Jingjing Guo; Shanshan Ru; Sunyuan Lv; Xiao Ying; Xiaonan Wang; Yingzhe Zhang

Apr 29, 2026